The objective of the MAGBBRIS Project is to enhance ischemic tissue remodelling by encapsulating EPCs-secretome into biocompatible nanocapsules labelled with  magnetic nanoparticles and fluorescent tags, allowing magnetic guidance and retention, simultaneous in vivo imaging and controlled release.

MAGBBRIS is funded within the framework of the EuroNanoMed III Joint Transnational Call
by the following National Founding Agencies:

Euronanomed3 logo

March 20, 2020

Nanoscale has published one of the first outcomes of the MAGBBRIS project: the synthesis of PLGA nanocapsules for drug delivery functionalized with three different contrast agents for medical imaging techniques. The nano...

January 20, 2020

Anna Roig, from the Nanoparticles and Nanocomposites Group at the Institute of Materials Science of Barcelona (ICMAB-CSIC) attended the IV International Symposium on Nanoparticles/Nanomaterials and Applications 2020 (ISN...

Please reload

CONSORTIUM PARTNERS

MAGBBRIS is a highly multidisciplinary consortium integrated by 6 partners from 5 European countries, involved in materials-science, biomedical and clinical research and industrial partnership. 

CONTACT US

UPCOMING EVENTS

​Teleconference

4th of February 2020

​Teleconference

31st of March 2020

​MAGBBRIS Annual Meeting

Milano, IT

5-6h of May 2020